IT-Bologna-MALPHIGI

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia1 trial
• Multiple myeloma1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Not yet recruiting1 trial

Lead sponsor

• Stichting Hemato-Oncologie voor Volwassenen Nederland2 trials

Running trials

• Recruiting

  Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy

  NCT07075016· Phase 3· Stichting Hemato-Oncologie voor Volwassenen Nederland· Source

  Contact: Dr Antonio Curti

• Active, not recruiting

  Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM

  NCT03673826· Phase 2· Stichting Hemato-Oncologie voor Volwassenen Nederland· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia1 recruiting